Rhodococcus equi: Clinical Manifestations, Virulence, and Immunity

Journal of Veterinary Internal Medicine

Volumn 25, Issue 6, 2011, Pages 1221-1230

  Giguere S ^a   Cohen, N D ^b   Keith Chaffin, M ^c   Hines, S A ^c   Hondalus, M K ^a   Prescott, J F ^d   Slovis, N M ^e  

^a UNIVERSITY OF GEORGIA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d UNIVERSITY OF GUELPH   (Canada)

^e HAGYARD EQUINE MEDICAL INSTITUTE   (United States)

Author keywords

Bacterial; Bacterial species; Bacterial virulence mechanisms; Cellular immunity; Immunology; Microbiology; Parenchymal disease; Pneumonia; Respiratory tract

Indexed keywords

ACTINOMYCETALES INFECTION; ANIMAL; ANIMAL DISEASE; HORSE; HORSE DISEASE; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; REVIEW; RHODOCOCCUS EQUI; VIRULENCE;

ACTINOMYCETALES INFECTIONS; ANIMALS; HORSE DISEASES; HORSES; RHODOCOCCUS EQUI; VIRULENCE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; RHODOCOCCUS EQUI;

EID: 81355161051     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00804.x     Document Type: Review

References (102)

1. Zink MC, Yager JA, Smart NL. Corynebacterium equi infections in horses, 1958-1984: A review of 131 cases. Can J Vet Res 1986;27:213-217.
2. Slovis NM, McCracken JL, Mundy G. How to use thoracic ultrasound to screen foals for Rhodococcus equi at affected farms. Proc Am Assoc Equine Pract 2005;51:274-278.
3. Venner M, Rodiger A, Laemmer M, et al. Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi. Vet J 2011. In press.
4. Falcon J, Smith BP, O'Brien TR, et al. Clinical and radiographic findings in Corynebacterium equi pneumonia of foals. J Am Vet Med Assoc 1985;186:593-599.
5. Chaffin MK, Cohen ND, Martens RJ, et al. Evaluation of the efficacy of gallium maltolate for chemoprophylaxis against pneumonia caused by Rhodococcus equi infection in foals. Am J Vet Res 2011;72:945-957.
6. Reuss SM, Chaffin MK, Cohen ND. Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987-2007). J Am Vet Med Assoc 2009;235:855-863.
7. Giguère S, Jacks S, Roberts GD, et al. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med 2004;18:568-573.
8. Stratton-Phelps M, Wilson WD, Gardner IA. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J Am Vet Med Assoc 2000;217:68-73.
9. Valdes A, Johnson JR. Septic pleuritis and abdominal abscess formation caused by Rhodococcus equi in a foal. J Am Vet Med Assoc 2005;227:960-963.
10. Hines MT. Rhodococcus equi. In: Sellon DC, Long MT, eds. Equine Infectious Diseases. Philadelphia, PA: Saunders; 2007:281-295.
11. Sweeney CR, Sweeney RW, Divers TJ. Rhodococcus equi pneumonia in 48 foals: Response to antimicrobial therapy. Vet Microbiol 1987;14:329-336.
12. Kenney DG, Robbins SC, Prescott JF, et al. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia. Equine Vet J 1994;26:246-248.
13. Madison JB, Scarratt WK. Immune-mediated polysynovitis in four foals. J Am Vet Med Assoc 1988;192:1581-1584.
14. Giguère S, Hondalus MK, Yager JA, et al. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 1999;67:3548-3557.
15. Chaffin MK, Honnas CM, Crabill MR, et al. Cauda equina syndrome, diskospondylitis, and a paravertebral abscess caused by Rhodococcus equi in a foal. J Am Vet Med Assoc 1995;206:215-220.
16. Janicek JC, Kramer J, Coates JR, et al. Intracranial abscess caused by Rhodococcus equi infection in a foal. J Am Vet Med Assoc 2006;228:251-253.
17. Barton MD, Embury DH. Studies of the pathogenesis of Rhodococcus equi infection in foals. Aust Vet J 1987;64:332-339.
18. Johnson JA, Prescott JF, Markham RJ. The pathology of experimental Corynebacterium equi infection in foals following intragastric challenge. Vet Pathol 1983;20:450-459.
19. Horowitz ML, Cohen ND, Takai S, et al. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J Vet Intern Med 2001;15:171-175.
20. Giguère S, Gaskin JM, Miller C, et al. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J Am Vet Med Assoc 2002;220:59-63.
21. Wada R, Kamada M, Anzai T, et al. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge. Vet Microbiol 1997;56:301-312.
22. Takai S, Sekizaki T, Ozawa T, et al. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun 1991;59:4056-4060.
23. Tkachuk-Saad O, Prescott J. Rhodococcus equi plasmids: Isolation and partial characterization. J Clin Microbiol 1991;29:2696-2700.
24. Takai S, Madarame H, Matsumoto C, et al. Pathogenesis of Rhodococcus equi infection in mice: Roles of virulence plasmids and granulomagenic activity of bacteria. FEMS Immunol Med Microbiol 1995;11:181-190.
25. Hondalus MK, Mosser DM. Survival and replication of Rhodococcus equi in macrophages. Infect Immun 1994;62:4167-4175.
26. Letek M, Ocampo-Sosa AA, Sanders M, et al. Evolution of the Rhodococcus equi vap pathogenicity island seen through comparison of host-associated vapA and vapB virulence plasmids. J Bacteriol 2008;190:5797-5805.
27. Takai S, Hines SA, Sekizaki T, et al. DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect Immun 2000;68:6840-6847.
28. Takai S, Iie M, Watanabe Y, et al. Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: Temperature-dependent expression and location of the antigens. Infect Immun 1992;60:2995-2997.
29. Tan C, Prescott JF, Patterson MC, et al. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can J Vet Res 1995;59:51-59.
30. Jain S, Bloom BR, Hondalus MK. Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol Microbiol 2003;50:115-128.
31. Coulson GB, Agarwal S, Hondalus MK. Characterization of the role of the pathogenicity island and vapG in the virulence of the intracellular actinomycete pathogen Rhodococcus equi. Infect Immun 2010;78:3323-3334.
32. von BK, Polidori M, Becken U, et al. Rhodococcus equi virulence-associated protein A is required for diversion of phagosome biogenesis but not for cytotoxicity. Infect Immun 2009;77:5676-5681.
33. Ren J, Prescott JF. The effect of mutation on Rhodococcus equi virulence plasmid gene expression and mouse virulence. Vet Microbiol 2004;103:219-230.
34. Russell DA, Byrne GA, O'Connell EP, et al. The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodococcus equi ATCC 33701. J Bacteriol 2004;186:5576-5584.
35. Letek M, Gonzalez P, Macarthur I, et al. The genome of a pathogenic rhodococcus: Cooptive virulence underpinned by key gene acquisitions. PLoS Genet 2010;6:e1001145, 1-17.
36. Sutcliffe IC. Cell envelope composition and organisation in the genus Rhodococcus. Antonie Van Leeuwenhoek 1998;74:49-58.
37. Gotoh K, Mitsuyama M, Imaizumi S, et al. Mycolic acid-containing glycolipid as a possible virulence factor of Rhodococcus equi for mice. Microbiol Immunol 1991;35:175-185.
38. Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 2005;11:638-644.
39. Wall DM, Duffy PS, Dupont C, et al. Isocitrate lyase activity is required for virulence of the intracellular pathogen Rhodococcus equi. Infect Immun 2005;73:6736-6741.
40. Macarthur I, Parreira VR, Lepp D, et al. The sensor kinase MprB is required for Rhodococcus equi virulence. Vet Microbiol 2011;147:133-141.
41. Pei Y, Parreira V, Nicholson VM, et al. Mutation and virulence assessment of chromosomal genes of Rhodococcus equi 103. Can J Vet Res 2007;71:1-7.
42. Hondalus MK, Diamond MS, Rosenthal LA, et al. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect Immun 1993;61:2919-2929.
43. Garton NJ, Gilleron M, Brando T, et al. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J Biol Chem 2002;277:31722-31733.
44. Fernandez-Mora E, Polidori M, Luhrmann A, et al. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic 2005;6:635-653.
45. Toyooka K, Takai S, Kirikae T. Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J Med Microbiol 2005;54:1007-1015.
46. Zink MC, Yager JA, Prescott JF, et al. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol 1987;14:295-305.
47. Benoit S, Benachour A, Taouji S, et al. H(2)O(2), which causes macrophage-related stress, triggers induction of expression of virulence-associated plasmid determinants in Rhodococcus equi. Infect Immun 2002;70:3768-3776.
48. Ren J, Prescott JF. Analysis of virulence plasmid gene expression of intra-macrophage and in vitro grown Rhodococcus equi ATCC 33701. Vet Microbiol 2003;94:167-182.
49. Luhrmann A, Mauder N, Sydor T, et al. Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids. Infect Immun 2004;72:853-862.
50. Hietala SK, Ardans AA. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet Microbiol 1987;14:307-320.
51. Darrah PA, Hondalus MK, Chen Q, et al. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 2000;68:3587-3593.
52. Kasuga-Aoki H, Takai S, Sasaki Y, et al. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: Cytokine production depends on the virulence levels of R. equi. Immunology 1999;96:122-127.
53. Martens RJ, Cohen ND, Jones SL, et al. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect Immun 2005;73:7040-7042.
54. Martens JG, Martens RJ, Renshaw HW. Rhodococcus (Corynebacterium) equi: Bactericidal capacity of neutrophils from neonatal and adult horses. Am J Vet Res 1988;49:295-299.
55. Takai S, Morozumi Y, Higashiyama S, et al. Nitroblue tetrazolium reduction by neutrophils of newborn foals, adult horses, and a foal infected with Rhodococcus (Corynebacterium) equi. Jpn J Vet Sci 1986;48:405-408.
56. Yager JA, Foster SF, Zink MC, et al. In vitro bactericidal efficacy of equine polymorphonuclear leukocytes against Corynebacterium equi. Am J Vet Res 1986;47:438-440.
57. Hietala SK, Ardans AA. Neutrophil phagocytic and serum opsonic response of the foal to Corynebacterium equi. Vet Immunol Immunopathol 1987;14:279-294.
58. Yager JA, Duder CK, Prescott JF, et al. The interaction of Rhodococcus equi and foal neutrophils in vitro. Vet Microbiol 1987;14:287-294.
59. Yager JA, Prescott CA, Kramar DP, et al. The effect of experimental infection with Rhodococcus equi on immunodeficient mice. Vet Microbiol 1991;28:363-376.
60. Kanaly ST, Hines SA, Palmer GH. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 1995;63:3037-3041.
61. Madarame H, Takai S, Matsumoto C, et al. Virulent and avirulent Rhodococcus equi infection in T-cell deficient athymic nude mice: Pathologic, bacteriologic and immunologic responses. FEMS Immunol Med Microbiol 1997;17:251-262.
62. Ross TL, Balson GA, Miners JS, et al. Role of CD4 + , CD8 + and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi. Can J Vet Res 1996;60:186-192.
63. Kanaly ST, Hines SA, Palmer GH. Failure of pulmonary clearance of Rhodococcus equi infection in CD4 + T-lymphocyte-deficient transgenic mice. Infect Immun 1993;61:4929-4932.
64. Nordmann P, Ronco E, Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun 1992;60:2748-2752.
65. Kanaly ST, Hines SA, Palmer GH. Transfer of a CD4 + Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun 1996;64:1126-1132.
66. Hines SA, Stone DM, Hines MT, et al. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4(+) and CD8(+) T lymphocytes. Clin Diagn Lab Immunol 2003;10:208-215.
67. Lopez AM, Hines MT, Palmer GH, et al. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin Diagn Lab Immunol 2002;9:1270-1276.
68. Patton KM, McGuire TC, Fraser DG, et al. Rhodococcus equi-infected macrophages are recognized and killed by CD8 + T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect Immun 2004;72:7073-7083.
69. Harris SP, Fujiwara N, Mealey RH, et al. Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes. Microbiology 2010;156:1836-1847.
70. Patton KM, McGuire TC, Hines MT, et al. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect Immun 2005;73:2083-2093.
71. Pargass IS, Wills TB, Davis WC, et al. The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells. Vet Immunol Immunopathol 2009;130:197-209.
72. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004;4:553-564.
73. Flaminio MJ, Nydam DV, Marquis H, et al. Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection. Clin Vaccine Immunol 2009;16:176-183.
74. Boyd NK, Cohen ND, Lim WS, et al. Temporal changes in cytokine expression of foals during the first month of life. Vet Immunol Immunopathol 2003;92:75-85.
75. Breathnach CC, Sturgill-Wright T, Stiltner JL, et al. Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol 2006;112:199-209.
76. Nerren JR, Martens RJ, Payne S, et al. Age-related changes in cytokine expression by neutrophils of foals stimulated with virulent Rhodococcus equi in vitro. Vet Immunol Immunopathol 2009;127:212-219.
77. Liu T, Nerren J, Liu M, et al. Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals. Vaccine 2009;27:674-683.
78. Ryan C, Giguère S, Hagen J, et al. Effect of age and mitogen on the frequency of interleukin-4 and interferon gamma secreting cells in foals and adult horses as assessed by an equine-specific ELISPOT assay. Vet Immunol Immunopathol 2010;133:66-71.
79. Ryan C, Giguère S. Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses. Clin Vaccine Immunol 2010;17:1896-1902.
80. Wagner B, Burton A, Ainsworth D. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory T(R)1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet Res 2010;41:47.
81. Jacks S, Giguère S, Crawford PC, et al. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin Vaccine Immunol 2007;14:669-677.
82. Liu M, Liu T, Bordin A, et al. Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi. Cytokine 2009;48:280-289.
83. Ryan C, Giguère S, Fultz L, et al. Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi. Vet Immunol Immunopathol 2010;138:198-205.
84. Sturgill TL, Strong D, Rashid C, et al. Effect of Propionibacterium acnes-containing immunostimulant on interferon-gamma (IFNgamma) production in the neonatal foal. Vet Immunol Immunopathol 2011;141:124-127.
85. Sturgill TL, Giguère S, Franklin RP, et al. Effects of inactivated parapoxvirus ovis on the cumulative incidence of pneumonia and cytokine secretion in foals on a farm with endemic infections caused by Rhodococcus equi. Vet Immunol Immunopathol 2011;140:237-243.
86. Caston SS, McClure SR, Martens RJ, et al. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals. Vet Ther 2006;7:361-375.
87. Martens RJ, Martens JG, Fiske RA. Rhodococcus equi foal pneumonia: Pathogenesis and immunoprophylaxis. Proc Am Assoc Equine Pract 1989;35:189-213.
88. Perkins GA, Yeagar A, Erb HN, et al. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma. Vet Ther 2001;3:334-346.
89. Chirino-Trejo JM, Prescott JF, Yager JA. Protection of foals against experimental Rhodococcus equi pneumonia by oral immunization. Can J Vet Res 1987;51:444-447.
90. Hooper-McGrevy KE, Wilkie BN, Prescott JF. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi. Vaccine 2005;23:5760-5767.
91. Harris SP, Hines MT, Mealey RH, et al. Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi. Vet Immunol Immunopathol 2011;14:312-316.
92. Madigan JE, Hietala S, Muller N. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J Reprod Fertil Suppl 1991;44:571-578.
93. Martens RJ, Martens JG, Fiske RA. Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet J 1991;12(Suppl):19-22.
94. Cauchard J, Sevin C, Ballet JJ, et al. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet Microbiol 2004;104:73-81.
95. Oliveira AF, Ruas LP, Cardoso SA, et al. Vaccination of mice with salmonella expressing VapA: Mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. PLoS ONE 2010;5:e8644.
96. Haghighi HR, Prescott JF. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection. Vet Immunol Immunopathol 2005;104:215-225.
97. Lopez AM, Hines MT, Palmer GH, et al. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi. Vaccine 2003;21:3815-3825.
98. Lopez AM, Townsend HG, Allen AL, et al. Safety and immunogenicity of a live-attenuated auxotrophic candidate vaccine against the intracellular pathogen Rhodococcus equi. Vaccine 2008;26:998-1009.
99. Pei Y, Nicholson V, Woods K, et al. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103 + Vet Microbiol 2007;125:100-110.
100. Kohler AK, Stone DM, Hines MT, et al. Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection. Infect Immun 2003;71:6329-6337.
101. Hong Y, Hondalus MK. Site-specific integration of Streptomyces PhiC31 integrase-based vectors in the chromosome of Rhodococcus equi. FEMS Microbiol Lett 2008;287:63-68.
102. van der Geize R, Grommen AWF, Hessels GI, et al. The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development. PLoS Pathogens 2011;7:e1002181. Available at www.plospathogens.org.